RECRUITINGINTERVENTIONAL
Danish Angle Closure Prevention Trial
About This Trial
To determine whether primary angle closure suspects (PACS) in a Caucasian population benefit from prophylactic laser iridotomy.
Who May Be Eligible (Plain English)
Who May Qualify:
- Primary angle closure suspect: ≥180 degrees (cumulative) irido-trabecular contact on darkroom gonioscopy, IOP\<21mmHg, no peripheral anterior synechiae, no glaucomatous optic neuropathy
- Best-corrected visual acuity (BCVA) \>0.8 on both eyes
- Caucasian
Who Should NOT Join This Trial:
- Pseudophakia
- Previous iridotomy
- Clinically significant cataract with indication for surgery,
- Gaucoma
- Uveitis
- Unstable retinal conditions
- Ocular malignancies
- PEX
- PDS
- Systemic or ocular corticosteroid treatment
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Primary angle closure suspect: ≥180 degrees (cumulative) irido-trabecular contact on darkroom gonioscopy, IOP\<21mmHg, no peripheral anterior synechiae, no glaucomatous optic neuropathy
* Best-corrected visual acuity (BCVA) \>0.8 on both eyes
* Caucasian
Exclusion Criteria:
* Pseudophakia
* Previous iridotomy
* Clinically significant cataract with indication for surgery,
* Gaucoma
* Uveitis
* Unstable retinal conditions
* Ocular malignancies
* PEX
* PDS
* Systemic or ocular corticosteroid treatment
Treatments Being Tested
PROCEDURE
Iridotomy
Peripheral iridotomy (size \>200µm)
Locations (5)
Aalborg University Hospital
Aalborg, Denmark
Aarhus University Hospital
Aarhus, Denmark
Rigshospitalet Glostrup
Glostrup Municipality, Denmark
Odense University Hospital
Odense, Denmark
Sygehus Lillebælt
Vejle, Denmark